002864 logo

Shaanxi Panlong Pharmaceutical Group Co., Ltd. Stock Price

SZSE:002864 Community·CN¥3.0b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

002864 Share Price Performance

CN¥0
-29.61 (-100.00%)
CN¥0
-29.61 (-100.00%)
Price CN¥0

002864 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet second-rate dividend payer.

2 Risks
1 Reward

Shaanxi Panlong Pharmaceutical Group Co., Ltd. Key Details

CN¥1.1b

Revenue

CN¥534.4m

Cost of Revenue

CN¥578.8m

Gross Profit

CN¥492.0m

Other Expenses

CN¥86.8m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
0.82
52.00%
7.80%
8.8%
View Full Analysis

About 002864

Founded
1997
Employees
926
CEO
Dezhu Zhang
WebsiteView website
www.pljt.com

Shaanxi Panlong Pharmaceutical Group Co., Ltd. researches and develops, produces, and sells Chinese patent medicines in China. It offers orthopedic, cardiovascular, cerebrovascular, digestive, respiratory, pediatrics, gynecology, hepatobiliary, rheumatism and bone injury, tonic, heat-clearing and detoxifying, and liver and gallbladder drugs, as well as supplements and traditional Chinese medicine anti-inflammatory products. The company was formerly known as Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd and changed its name to Shaanxi Panlong Pharmaceutical Group Co., Ltd. in May 2026. Shaanxi Panlong Pharmaceutical Group Co., Ltd. was founded in 1997 and is based in Xi'an, China.

Recent 002864 News & Updates

Recent updates

No updates